Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib + Vemurafenib in Metastatic Melanoma
NCT02202200Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in melanoma, sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
palbociclib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02202200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02202200.